Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France.
COVID-19
Neutralizing antibodies
SARS-CoV-2, Nursing homes
Vaccine
Journal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
received:
19
11
2021
revised:
08
03
2022
accepted:
14
03
2022
pubmed:
22
3
2022
medline:
27
4
2022
entrez:
21
3
2022
Statut:
ppublish
Résumé
To describe COVID-19 breakthrough infections in two nursing homes (NHs) sites of active COVID-19 clusters despite optimal vaccination coverage. A cross-sectional study was conducted in two NHs of south-western France, following the investigation of COVID-19 clusters (February-March 2021). SARS-CoV-2-confirmed infection was defined by positive RT-PCR. Antibodies neutralization capacities were tested in a subgroup of fully-vaccinated and seropositive-residents. Of the 152 residents, 66% were female with median age 87 years (IQR: 80.0-90.2). Overall, 132 (87%) residents received 2 doses of vaccine, 14 (9%) one dose and 6 (4%) were unvaccinated. Forty-seven (31%) residents had confirmed infection (45 (98%) with variant 20I/501Y.V1). All 6 non-vaccinated residents, 4 /14 who had one dose and 37/132 that had two doses, were infected. Of the 39 residents reporting symptoms, 12 and 3 presented severe and critical disease, respectively. One resident with a confirmed infection died. Infected-residents had a median anti-S IgG titre of 19 116.0 (IQR: 3 028.0-39 681.8 AU/mL), 19 times higher than that of non-infected vaccinated persons (1,207.0; IQR: 494.0-2,782.0). In the subgroup of 19 residents tested for neutralizing antibodies, the neutralizing titre (50%) was strongly positively correlated with the anti-S IgG titre (correlation coefficient = 0.83), and 1.5 times higher for the infected than non-infected residents [5.9 (IQR: 5.3-6.9) vs. 3.6 (2.9-3.8)]. Institutionalized elderly persons who undergo breakthrough infection develop higher titres of anti-S IgGs, which are strongly correlated with the neutralizing capacity of the antibodies. These results advocate for additional vaccine doses in this population.
Identifiants
pubmed: 35313222
pii: S1386-6532(22)00070-1
doi: 10.1016/j.jcv.2022.105134
pmc: PMC8923035
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Immunoglobulin G
0
Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105134Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.
Références
Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
JAMA. 2021 Jul 21;:
pubmed: 34287620
Clin Infect Dis. 2022 Mar 1;74(4):707-710
pubmed: 34050731
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Cell. 2021 Apr 29;184(9):2372-2383.e9
pubmed: 33743213
JAMA Intern Med. 2020 Jun 1;180(6):817-818
pubmed: 32275292